Tricuspid regurgitation is a common finding in patients with left-sided valvular or myocardial
disease, often being a marker for late-stage chronic heart failure with a grim prognosis …

Heart failure with preserved ejection fraction (HFpEF) is associated with high morbidity and
mortality. Important risk factors for the development of HFpEF are similar to risk factors for the …

Background Tricuspid regurgitation is a prevalent disease associated with high morbidity
and mortality, with few treatment options. The aim of the TRILUMINATE trial is to evaluate …

Objectives: A large, prospective international registry was developed to evaluate the initial
clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices …

Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and
mortality rates with limited treatment options. Objectives: The authors report the 6-month …

Background Tricuspid regurgitation (TR), if untreated, is associated with an adverse impact
on long‐term outcomes. In recent years, there has been an increasing enthusiasm about …

Objectives The aim of this registry was to evaluate the feasibility and safety of transcatheter
tricuspid valve implantation (TTVI) in patients with extreme surgical risk. Background …

With the expanding use of cardiac implantable electronic device (CIEDs) in an ever-aging
population, the looming problem of CIED-associated interference with the tricuspid valve is …

Tricuspid valve disease, and particularly tricuspid regurgitation, is a highly prevalent
condition with a complex pathophysiology and long-term adverse consequences. Although …

Significant tricuspid regurgitation (TR) is a common finding, affecting about one in twenty-
five subjects among the elderly and presenting more frequently in women than in men. This …